Director of Access, International (Hybrid)
Insulet
This listing was originally posted on Insulet's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moJob Summary
Job Title: Director of Access, InternationalThe Director of Access, International is a key leadership role within the International Value & Access organisation, responsible for shaping and executing reimbursement, coverage and market access strategies across international markets. This role plays a critical part in ensuring that people living with diabetes have timely and sustainable access to Insulet's portfolio of innovative technologies.
Working closely with the Director of Value, Director of Policy and Public Affairs and country market access leaders, and cross-functional partners, the Director of Access will lead the development and execution of access strategies that optimise reimbursement, protect and enhance value, and accelerate adoption across both existing and future product portfolios.
As a recognised reimbursement and payer expert, the Director of Access International will influence strategic decisions across the business while building market access capabilities, driving excellence and establishing Insulet as a trusted partner to payers and healthcare systems.
Responsibilities
Required Skills and Competencies
Education and Experience
Additional Information
#LI-JW1 #LI-Hybrid
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
Please read our Privacy Notice to learn how Insulet handles your personal information when you apply for a vacancy with us here.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Insulet?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Insulin Pump
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo